Harris P, Takeda A, Loveman E, Hartwell D. Time to full publication of studies of anti-cancer drugs for breast cancer, and the potential for publication bias. International Journal of Technology Assessment in Health Care 2010;26(1):110-6.
Oliver S, Bagnall AM, Thomas J, Shepherd J, Sowden A, White I, Dinnes J, Rees R, Colquitt J, Oliver K, and Garret Z. Randomised controlled trials for policy interventions: a review of reviews and meta-regression. Health Technology Assessment 2010;14(16).
Takeda A, Loveman E, Harris P, Hartwell D, Welch K. Time to full publication of studies of novel chemotherapy drugs for breast cancer and the potential for publication bias: a short systematic review. Health Technology Assessment 2008;12(32).
Bryant J, Loveman E, Cave C, Chase D, Milne R. Endocrinology trial design: Adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults. Journal of Endocrinology 2002;175:545-52.